Late-Breaking Data Confirms Safety of Axon Therapies’ Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months SAVM procedure quick and easy to perform with high success rate and no significant increase in procedure-related…